Pragmatic comparison of β 2 -agonist side effects within the Worldwide Atosiban versus Beta Agonists Study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 135-141

  Chan, Jerry ^a   Cabrol, Dominique ^b   Ingemarsson, Ingemar ^c   Marsal, Karel ^c   Moutquin, Jean Marie ^d   Fisk, Nicholas M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Hôpital Cochin APHP Université René Descartes ^*  (France)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Preterm labour; Side effects; Tocolysis; Agonist

Indexed keywords

ATOSIBAN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; RITODRINE; SALBUTAMOL; TERBUTALINE; UTERUS SPASMOLYTIC AGENT; ARGIPRESTOCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DELIVERY; DIASTOLIC BLOOD PRESSURE; DRUG INDUCED HEADACHE; DYSPNEA; FEMALE; GLUCOSE BLOOD LEVEL; HEART PALPITATION; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; NAUSEA; PREMATURE LABOR; PRIORITY JOURNAL; TACHYCARDIA; TREMOR; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECISION MAKING; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; PREGNANCY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-AGONISTS; ADULT; DECISION MAKING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREVALENCE; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 33748370534     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.030     Document Type: Article

References (40)

1. Gyetvai K., Hannah M.E., Hodnett E.D., and Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 94 (1999) 869-877
2. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 327 (1992) 308-312
3. Boyle J.G. Beta-adrenergic agonists. Clin Obstet Gynecol 38 (1995) 688-696
4. Ingemarsson I., Arulkumaran S., and Kottegoda S.R. Complications of beta-mimetic therapy in preterm labour. Aust NZ J Obstet Gynaecol 25 (1985) 182-189
5. Hudgens D.R., and Conradi S.E. Sudden death associated with terbutaline sulfate administration. Am J Obstet Gynecol 169 (1993) 120-121
6. Levy D.L. Morbidity caused by terbutaline infusion pump therapy. Am J Obstet Gynecol 170 (1835)
7. Perry Jr. K.G., Morrison J.C., Rust O.A., Sullivan C.A., Martin R.W., and Naef III R.W. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 173 (1995) 1273-1277
8. Schwarz R., and Retzke U. Cardiovascular effects of terbutaline in pregnant women. Acta Obstet Gynecol Scand 62 (1983) 419-423
9. Lamont R.F. The pathophysiology of pulmonary oedema with the use of beta-agonists. Br J Obstet Gynaecol 107 (2000) 439-444
10. Price PH. Review of betamimetic drugs for tocolysis. Report to special FDA public meeting on re-evaluation of ritodrine labelling; 1992.
11. Regenstein A.C., Belluomini J., and Katz M. Terbutaline tocolysis and glucose intolerance. Obstet Gynecol 81 (1993) 739-741
12. Lindenbaum C., Ludmir J., Teplick F.B., Cohen A.W., and Samuels P. Maternal glucose intolerance and the subcutaneous terbutaline pump. Am J Obstet Gynecol 166 (1992) 925-928
13. Braden G.L., von Oeyen P.T., Germain M.J., Watson D.J., and Haag B.L. Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences. Kidney Int 51 (1997) 1867-1875
14. Shen O., Lavie O., Grisaru S., Aboulafia Y., and Diamant Y.Z. Elevated serum liver enzyme concentrations during ritodrine therapy. Acta Obstet Gynecol Scand 75 (1996) 183-184
15. Katz V.L., and Seeds J.W. Fetal and neonatal cardiovascular complications from beta-sympathomimetic therapy for tocolysis. Am J Obstet Gynecol 161 (1989) 1-4
16. Friedman D.M., Blackstone J., Young B.K., and Hoskins I.A. Fetal cardiac effects of oral ritodrine tocolysis. Am J Perinatol 11 (1994) 109-112
17. Groome L.J., Goldenberg R.L., Cliver S.P., Davis R.O., and Copper R.L. Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol 167 (1992) 873-879
18. Bremme K., Eneroth P., Carsjo B.M., and Nilsson B. Blood pressure regulation in third-trimester pregnant women receiving tocolytic terbutaline infusion. Eur J Obstet Gynecol Reprod Biol 23 (1986) 53-60
19. Hanssens M., Keirse M.J., and Symonds E.M. Activation of the rennin-angiotensin system during ritodrine treatment in preterm labor. Am J Obstet Gynecol 162 (1990) 1048-1053
20. Richter R., and Hinselmann M.J. The treatment of threatened premature labor by betamimetic drugs: a comparison of fenoterol and ritodrine. Obstet Gynecol 53 (1979) 81-87
21. Kosasa T.S., Nakayama R.T., Hale R.W., Rinzler G.S., and Freitas C.A. Ritodrine and terbutaline compared for the treatment of preterm labor. Acta Obstet Gynecol Scand 64 (1985) 421-426
22. Lipshitz J., and Lipshitz E.M. Uterine and cardiovascular effects of fenoterol and hexoprenaline in prostaglandin F2 alpha-induced labor in humans. Obstet Gynecol 63 (1984) 396-400
23. Lipshitz J., Baillie P., and Davey D.A. A comparison of the uterine beta2-adrenoreceptor selectivity of fenoterol, hexoprenaline, ritodrine and salbutamol. S Afr Med J 50 (1976) 1969-1972
24. Beall M.H., Edgar B.W., Paul R.H., and Smith-Wallace T. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 153 (1985) 854-859
25. Caritis S.N., Toig G., Heddinger L.A., and Ashmead G. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 150 (1984) 7-14
26. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 108 (2001) 133-142
27. The European Atosiban Investigators Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 80 (2001) 413-422
28. The French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 98 (2001) 177-185
29. Moutquin J.M., Sherman D., Cohen H., et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182 (2000) 1191-1199
30. Reihsaus E., Innis M., MacIntyre N., and Liggett S.B. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8 (1993) 334-339
31. Dishy V., Sofowora G.G., Xie H.G., et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345 (2001) 1030-1035
32. Wood A.J. Variability in beta-adrenergic receptor response in the vasculature: role of receptor polymorphism. J Allergy Clin Immunol 110 (2002) S318-S321
33. RCOG. RCOG, London; 1997.
34. Leveno K.J., and Cunningham F.G. Beta-adrenergic agonists for preterm labor. N Engl J Med 327 (1992) 349-351
35. Benedetti T.J., and Caritis S.N. Treatment of preterm labor with beta-adrenergic agonist ritodrine. N Engl J Med 327 (1992) 1758-1760
36. Besinger R.E. A systematic review of adverse events documented in the use of currently available treatment of preterm labour. Res Clin Forums 16 (1994) 89-126
37. MacLennan F.M., Thomson M.A., Rankin R., Terry P.B., and Adey G.D. Fatal pulmonary oedema associated with the use of ritodrine in pregnancy. Case report. Br J Obstet Gynaecol 92 (1985) 703-705
38. Page I.J., Atalla A., and Young K. Fatal pulmonary oedema associated with the use of ritodrine in pregnancy. Br J Obstet Gynaecol 93 (1986) 197
39. Taslimi M.M., Sibai B., and Amon E. A national survey on preterm labor. Am J Obstet Gynecol 160 (1989) 1348-1360
40. Dennedy M.C., Houlihan D.D., McMillan H., and Morrison J.J. Beta2- and beta3-adrenoreceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 187 (2002) 641-647